Biotechnology
Swiss companies operating in the same biotechnology industry
The list below has Swiss companies that operate under the same industry, biotechnology. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as MODERNA INC or those with the best price dynamics like MOLECULAR PARTNERS, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 GISGILEAD SCIENCES | 72.583 B CHF | 58.007 CHF | −1.92% | 15 | 0.18 | 179.26 | 0.32 CHF | −92.01% | 4.65% | Health Technology | Buy |
 0QFMODERNA INC | 51.058 B CHF | 129.230 CHF | −2.48% | 40 | 0.48 | — | −14.14 CHF | −233.31% | 0.00% | Health Technology | Buy |
 22UABIONTECH SEDR | 21.088 B CHF | 88.499 CHF | −0.99% | 120 | 3.67 | 204.93 | 0.43 CHF | −98.15% | 0.00% | Health Technology | Buy |
 BM8BIOMARIN PHARMA | 14.298 B CHF | 70.994 CHF | −12.25% | 70 | 0.66 | 73.65 | 0.96 CHF | +183.03% | 0.00% | Health Technology | Buy |
 1CGCRISPR THERAPEUTIC | 4.751 B CHF | 53.333 CHF | −2.17% | 47 | 0.27 | — | −2.46 CHF | +60.09% | 0.00% | Health Technology | Buy |
 NVV1NOVAVAX INC | 2.108 B CHF | 14.155 CHF | −18.04% | 70 | 0.11 | — | −2.87 CHF | +78.22% | 0.00% | Health Technology | Buy |
 DYF1DYNAVAX TECHNOLOGI | 1.421 B CHF | 10.855 CHF | −1.32% | 500 | 0.58 | 222.83 | 0.05 CHF | −96.59% | 0.00% | Health Technology | Strong buy |
 PPGNPOLYPEPTIDE N | 1.093 B CHF | 32.75 CHF | −1.06% | 28.256 K | 1.30 | — | −1.52 CHF | −198.61% | 0.00% | Health Technology | Neutral |
| 8H0POLYPEPTIDE GROUP | 1.093 B CHF | 32.559 CHF | −0.84% | 200 | 2.54 | — | −1.52 CHF | −198.61% | 0.00% | Health Technology | Neutral |
 YTSNKUROS BIOSCIENCES | 416.221 M CHF | 11.079 CHF | +13.22% | 850 | 1.56 | — | −0.38 CHF | −63.13% | 0.00% | Health Technology | Strong buy |
| KURNKUROS N | 416.221 M CHF | 12.50 CHF | +5.75% | 265.218 K | 0.78 | — | −0.38 CHF | −63.13% | 0.00% | Health Technology | Strong buy |
 6MLMOLECULAR PARTNERS | 164.152 M CHF | 5.348 CHF | +46.60% | 200 | 0.15 | — | −1.78 CHF | −19.89% | 0.00% | Health Technology | Neutral |
| MOLNMOLECULAR PARTNERS N | 164.152 M CHF | 5.450 CHF | +21.79% | 145.224 K | 3.15 | — | −1.78 CHF | −19.89% | 0.00% | Health Technology | Neutral |
 GBYSANGAMO THERAPEUTI | 113.219 M CHF | 0.516 CHF | +7.50% | 2 K | — | — | −1.67 CHF | −123.52% | 0.00% | Health Technology | Buy |
 1S9SERES THERAPEUTICS | 108.058 M CHF | 0.767 CHF | −19.85% | 100 | 0.13 | — | −0.55 CHF | +74.01% | 0.00% | Health Technology | Buy |